- Presentations
- 2
- Markets
- 1
Kanjinti is a brand of Trastuzumab marketed by Amgen, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Trastuzumab
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- 150 mg/7.15 mL powder for injection, 420 mg/20 mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Kanjinti 150 mg/7.15 mL powder for injectionIntravenous Cold chain | Amgen | US FDA | Available on request |
| Kanjinti 420 mg/20 mL powder for injectionIntravenous Cold chain | Amgen | US FDA | Available on request |
Equivalent brands
Other brands of Trastuzumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Kanjinti
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.